| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 09/25/2003 | US20030180252 Methods and compositions for enhancing immune response and for the production of in vitro Mabs |
| 09/25/2003 | US20030180249 Storage stability; mixture containing ion exchange resin |
| 09/25/2003 | US20030180244 Use of oligomers and polymers for drug solublization, stabilization, and delivery |
| 09/25/2003 | US20030180228 Aerosol container for formulations of salmeterol xinafoate |
| 09/25/2003 | US20030180227 Pharmaceutical formulations for dry powder inhalers in the form of hard-pellets |
| 09/25/2003 | US20030180222 Using paramagnetic chelate peptide compound |
| 09/25/2003 | US20030178022 Pressurized metered dose inhaler (PMDI) actuators and medicinal aerosol solution formulation products comprising therse actuators |
| 09/25/2003 | CA2748620A1 Naltrexone hydrochloride compositions |
| 09/25/2003 | CA2479295A1 Progesterone oral drug delivery system |
| 09/25/2003 | CA2479212A1 Central airway administration for systemic delivery of therapeutics |
| 09/25/2003 | CA2478867A1 Formulations of anthraquinone derivatives |
| 09/25/2003 | CA2478758A1 Pharmaceutical compositions comprising 2-(4-ethoxy-phenyl)-3-(4-methanesulfonyl-phenyl)-pyrazolo'1,5-bipyridazine in nanoparticulate form |
| 09/25/2003 | CA2478248A1 Methods and devices for detection and therapy of atheromatous plaque |
| 09/25/2003 | CA2478074A1 Percutaneous absorption promoters and compositions for treating athlete's foot |
| 09/25/2003 | CA2477826A1 A low fat cocoa extract |
| 09/25/2003 | CA2463659A1 Compositions and methods for the detection, diagnosis and therapy of hematological malignancies |
| 09/25/2003 | CA2459836A1 Oligo(ethylene glycol)-terminated 1,2-dithiolanes and their conjugates useful for preparing self-assembled monolayers |
| 09/24/2003 | EP1346732A2 Dosage forms for hygroscopic active ingredients |
| 09/24/2003 | EP1346731A1 Conjugates for treating inflammatory disorders and associated tissue damage |
| 09/24/2003 | EP1346730A1 Pretargeting methods and novel pretargeting conjugates |
| 09/24/2003 | EP1346729A1 Targeting of myocardial angiogenesis through CD13/APN |
| 09/24/2003 | EP1346727A2 Method for obtaining antigenic aggregates and the use thereof in formulations |
| 09/24/2003 | EP1346649A2 Water dispersible compositions containing natural hydrophobic pigment, method of preparing same and their use |
| 09/24/2003 | EP1346640A1 A low fat cocoa extract |
| 09/24/2003 | EP1346218A1 Tripeptide of fc gama riia |
| 09/24/2003 | EP1346059A1 Photochemical internalization for delivery of molecules into the cytosol |
| 09/24/2003 | EP1346041A2 Therapeutic agents and methods of use thereof for treating an amyloidogenic disease |
| 09/24/2003 | EP1345982A2 Synthesis of high molecular weight non-peptidic polymer derivatives |
| 09/24/2003 | EP1345979A2 Novel polyesters, method for producing the same and depot medicaments produced from these polyesters |
| 09/24/2003 | EP1345968A2 Crystals of whole antibodies and fragments thereof and methods for making and using them |
| 09/24/2003 | EP1345956A2 Intracellular delivery of biological effectors by novel transporter peptide sequences |
| 09/24/2003 | EP1345893A2 Sulphur-containing amphiphilic agents for the transfer of biologically active molecules into cells |
| 09/24/2003 | EP1345743A1 Electroprocessed collagen |
| 09/24/2003 | EP1345682A2 Preparation of microparticles having improved flowability |
| 09/24/2003 | EP1345630A1 Stabilised radiopharmaceutical compositions |
| 09/24/2003 | EP1345629A2 Particles for inhalation having sustained release properties |
| 09/24/2003 | EP1345628A2 Conjugates of erythropoietin (pep) with polyethylene glycol (peg) |
| 09/24/2003 | EP1345627A1 Targeted modification of intracellular compounds |
| 09/24/2003 | EP1345626A2 Novel pharmaceutical compositions based on anticholinergic agents and dopamine agonists |
| 09/24/2003 | EP1345623A2 Immunogenic proteoliposomes, and uses thereof |
| 09/24/2003 | EP1345620A2 Stable enzymatic wound debrider |
| 09/24/2003 | EP1345619A2 Use of a composition for the stimulation of nerve growth, the inhibition of scar tissue formation, the reduction of secondary damage and/or the accumulation of macrophages |
| 09/24/2003 | EP1345607A1 Therapeutic combination of amlodipine and benazepril / benazeprilat |
| 09/24/2003 | EP1345605A1 Thermoformable solid pharmaceutical composition for controlled release of perindopril |
| 09/24/2003 | EP1345594A1 Thermoformable solid pharmaceutical composition for controlled release of ivabradine |
| 09/24/2003 | EP1345592A2 Rapidly dispersing pharmaceutical composition comprising effervescent agents |
| 09/24/2003 | EP1345591A1 Pharmaceutical aerosol formulation |
| 09/24/2003 | EP1345589A1 Solvent systems for pharmaceutical agents |
| 09/24/2003 | EP1345587A1 Ionophore antibiotic formulations |
| 09/24/2003 | EP1345568A2 Stable skin conditioning compositions containing retinoid boosters |
| 09/24/2003 | EP1345549A1 Dispensing device |
| 09/24/2003 | EP1345502A1 Creatine/citric acid compound, method for the production of the same and the use thereof |
| 09/24/2003 | EP1200065B1 Intravaginal clindamycin ovule composition |
| 09/24/2003 | EP1085856B1 Pressurized metered dose inhalers and pharmaceutical aerosol formulations comprising a beta-agonist |
| 09/24/2003 | EP0982988B1 Substantially pure zonulin, a physiological modulator of mammalian tight junctions |
| 09/24/2003 | EP0969871B1 Method for the production of homogenous water-free formulations containing glycerophospholipids and polar or lipophilic substances |
| 09/24/2003 | EP0938345B1 Aqueous-based pharmaceutical composition |
| 09/24/2003 | EP0918509B1 Biocompatible devices with foam scaffolds |
| 09/24/2003 | CN1444496A New use of lipase inhibitors |
| 09/24/2003 | CN1444489A Aerosol container for formulations of salmeterol xinafoate |
| 09/24/2003 | CN1444488A Use and improvement of honey in wound dressings |
| 09/24/2003 | CN1444482A Pharmaceutical compositions containing tobramycin and xanthan gum |
| 09/24/2003 | CN1444480A Highly absorbable solid preparation |
| 09/24/2003 | CN1444478A Use of celecoxib composition for fast pain relief |
| 09/24/2003 | CN1444474A Nonoral preparation having three-layer structure |
| 09/24/2003 | CN1444473A Composition and drug form for curing oral nosomycosis |
| 09/24/2003 | CN1444472A Plasmid DNA (Lipogenes TM) and nucleas-containing location signal/fusogene conjogates drug encapsulating into targeted liposomes complex |
| 09/24/2003 | CN1444450A Allantoin-containing skin cream |
| 09/24/2003 | CN1443532A Flurbiprofenbab preparation and its preparation method |
| 09/24/2003 | CN1443531A Oral cavity adhesive plaster composition for curing gingival disease, laryngopharyngitis and halitosis |
| 09/24/2003 | CN1443529A Liposome enveloping fruit acid, its preparation method and application |
| 09/24/2003 | CN1121875C Pharmaceutical compositions for freeze drying |
| 09/24/2003 | CN1121860C Antifungal composition with enhanced bioavailability |
| 09/24/2003 | CN1121854C Trnasdermal device containing polyvinylpyrrolidone as solubility accelerator |
| 09/24/2003 | CN1121853C Pharmaceutical compositions for hardly soluble active substances |
| 09/23/2003 | US6624317 Taxoid conjugates as antimitotic and antitumor agents |
| 09/23/2003 | US6624298 Adjusted polysaccharide for use in the paints, construction materials, cosmetics and detergents |
| 09/23/2003 | US6624246 Method for the preparation of 1-benzotriazolyl carbonate esters of poly(ethylene glycol) |
| 09/23/2003 | US6624210 (Meth)acrylate ester copolymer with (meth)acrylate containing tertiary amine group, plasticizer, and emulsifier; powders, pastes, aqueous suspension; encapsulation; drug delivery |
| 09/23/2003 | US6624203 Nucleotide, a nucleoside or a purine or pyrimidine base; 0. 00001 to about 0.05 percent by weight a cationic, polymeric preservative display an effective preservative capacity, and an increased capacity over state-of-the-art preservative |
| 09/23/2003 | US6624193 Preventive and therapeutic agents for eye diseases |
| 09/23/2003 | US6624178 Novel compounds of the pyridinium series useful for the management of diabetes and aging-related vascular complications, including kidney disease, nerve damage, atherosclerosis, retinopathy, dermatological disorders and |
| 09/23/2003 | US6624142 Trimethyl lock based tetrapartate prodrugs |
| 09/23/2003 | US6623957 Immunotherapy for T-cell mediated autoimmune disease |
| 09/23/2003 | US6623950 Modified enzymes having polymer conjugates |
| 09/23/2003 | US6623765 Microemulsion and micelle systems for solubilizing drugs |
| 09/23/2003 | US6623764 Biodegradable targetable microparticle delivery system |
| 09/23/2003 | US6623762 Simple non-toxic system, deliverable by syringe or needle-free systems, is inexpensive and reliable and aids in parenteral drug delivery or mass immunization campaigns by reducing need for repeated injections |
| 09/23/2003 | US6623756 Directly compressed solid dosage articles |
| 09/23/2003 | US6623755 Pharmaceutical tablets |
| 09/23/2003 | US6623749 Medical device containing polyhydroxyalkanoate treated with oxidizing agent to remove endotoxin |
| 09/23/2003 | US6623744 For hand preparation such as a lotion or as a presurgical scrub replacement |
| 09/23/2003 | US6623739 Oil-in-water emulsions containing metabolizable oil and alpha tocopherol; enhancing immune responses to given antigen |
| 09/23/2003 | US6623731 Modified amino acid compounds useful in the drug delivery of bioactive agents such as recombinant human growth hormone (rhGH); dosage units; synthesis |
| 09/23/2003 | US6623722 Ultrasound echogenic contrast agents; higher yield; narrower size distribution; thinner shells; using such as ethanol in aqueous spray solution |
| 09/23/2003 | US6623472 Method for inducing therapeutically-effective proteins |
| 09/23/2003 | CA2301019C Anti-bacterial/anti-viral coatings, coating process and parameters thereof |
| 09/23/2003 | CA2285005C Sequential release throat drops for relief of cough and cold |
| 09/23/2003 | CA2268927C Aqueous-based pharmaceutical composition |
| 09/23/2003 | CA2131366C Self-assembling diketopiperazine drug delivery system |